
GMAB vs RPRX
$GMAB vs $RPRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GMAB vs RPRX: the quick read
- ·RPRX is the larger company by market cap ($22.69B vs $21.46B).
- ·RPRX has been more active on our scanner (70 vs 50 alerts in 30 days).
- ·RPRX has the smaller float (336.4M vs 613.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 70 and 50 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 6% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
- ·RPRX pays a dividend and GMAB does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GMAB and RPRX on TheDesperateTrader.
- Is GMAB or RPRX the better stock?
- "Better" depends on your goal, and these two are not alike. RPRX is the larger company by market cap ($22.69B vs $21.46B). RPRX has been more active on our scanner (70 vs 50 alerts in 30 days). RPRX has the smaller float (336.4M vs 613.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GMAB and RPRX?
- The differences that matter: they are not in the same business - GMAB is pharmaceutical preparations and RPRX is pharmaceutical preparations; they are similar in size ($21.46B vs $22.69B); they trade at very different share prices ($34.53 vs $59.33); GMAB sits at 92% of its 52-week range against 83% for RPRX; only RPRX pays a dividend; our scanner flagged GMAB 50 times in the last 30 days against 70 for RPRX. Everything above is measured from the latest completed session and SEC filings.
- Which of GMAB and RPRX is more active right now?
- Right now GMAB is at about 1.1x its normal volume and RPRX is at about 0.7x, so GMAB is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GMAB or RPRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GMAB and RPRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.